News

Eli Lilly: Positioned For Robust Q1 As Orforglipron Enhances Long-Term Outlook
Eli Lilly's Orforglipron shines in Phase III trials, potentially leading diabetes and obesity treatment by 2026. See what to ...
IndyCar4d
Crank up the Boost! How Hybrid Power Shakes up the Indy 500 Open Test
Stay up to speed on the latest INDYCAR news, behind-the-scenes driver content, exclusive offers and more — delivered straight to your inbox!
Jim Cramer Calls Eli Lilly and Company (LLY) a ‘Game Changer’ After Obesity Pill Trial Success
We recently published a list of Jim Cramer Says Trump’s Fed Chair Tussle Is Like “The Godfather” & Discusses These 10 Stocks.
IndyCar4d
Graham Rahal Makes Huge Save after Brushing Wall at Indy 500 Open Test
Stay up to speed on the latest INDYCAR news, behind-the-scenes driver content, exclusive offers and more — delivered straight to your inbox!